Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Klonbiyotek logo — Innovative biotech solutions in English drive advancements i...

Klonbiyotek

Innovative biotech solutions in English drive advancements in healthcare, agriculture, and environmental sustainability.

Founded 2018 Turkey Turkey 1 employees Seed Total: $130.00K Biotechnology, Health Care

General Information

Company Name Klonbiyotek
Founded Year 2018
Location Turkey Turkey
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology, Health Care
Funding Stage Seed
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Klonbiyotek. To contact Klonbiyotek, visit klonbiyotek.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Klonbiyotek compare?

A PDF of Klonbiyotek and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Klonbiyotek soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Klonbiyotek

Klonbiyotek Biyoteknoloji is a dynamic player in the biotechnology sphere, strategically positioned in Kayseri, Turkey. Established in 2018, the company has committed itself to the pivotal sectors of healthcare, agriculture, and environmental sustainability. Their mission, as captured in their slogan, "Innovative biotech solutions," is to reduce dependency on imported diagnostic kits by enhancing local production capabilities.

The company's core focus lies in the research and development of diagnostic test systems specifically targeting animal health. This effort is complemented by their expertise in product development and technology transfer, further cementing their role in the biotechnology and healthcare industries.

Klonbiyotek attracted early financial backing with a $100.00K seed investment in August 2019, led by investor ERBAN. This financial support underscores investor confidence in Klonbiyotek's potential to innovate and drive meaningful change in local and global markets.

Business keywords: biotech solutions, animal health, diagnostic test systems, local manufacturing, technology transfer, R&D, domestic production, import reduction, agriculture innovation, environmental sustainability

Services & Products

Development of rapid diagnostic tests for animals
Manufacturing of veterinary diagnostic kits
Research and prototyping in veterinary virology

Target Customers

Veterinarians Livestock farmers Pet owners Agricultural businesses Research institutions in veterinary science

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $100.00K 1
ERBAN
01 Aug 2019
Seed $30.00K 1
ERBAN
01 Apr 2019

Klonbiyotek Alternatives & Competitors

View All Alternatives
Klonbiyotek vs
Olmix
Olmix France

The partner of choice for farmers towards the agro-ecological transition.

Venture round
462 employees
Agriculture, Biotechnology
Klonbiyotek vs
Thrixen
Thrixen Singapore

Unlocking the next generation of simple, affordable & accessible diagnostics

Venture round
10 employees
Biotechnology, Health Care
Klonbiyotek vs
Vitrosens Biotechnology
Vitrosens Biotechnology Turkey

Accessible, Reliable Diagnostics for Human & Animal Health | Rapid POCT & Molecular Solutions

63 employees
Biotechnology, Health Care
View all alternatives

FAQ About Klonbiyotek

Innovative biotech solutions in English drive advancements in healthcare, agriculture, and environmental sustainability.
Klonbiyotek was founded in 2018.
Klonbiyotek is headquartered in Turkey.
Klonbiyotek operates in Biotechnology and Health Care. Its work centres on biotech solutions, animal health, diagnostic test systems and local manufacturing. Its customers include Veterinarians, Livestock farmers and Pet owners.
Klonbiyotek has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Klonbiyotek has approximately 1 employees.
Klonbiyotek has completed 2 funding rounds, raising a total of $130.00K. The latest funding stage is Seed.
Klonbiyotek offers: Development of rapid diagnostic tests for animals, Manufacturing of veterinary diagnostic kits, Research and prototyping in veterinary virology.
Top alternatives and competitors to Klonbiyotek include Olmix, Thrixen, Vitrosens Biotechnology, CTI Science, Stembio Cell and Tissue Technologies Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Klonbiyotek and Olmix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Klonbiyotek, https://bouncewatch.com/company/klonbiyotek, updated 26 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout